semaglutide for cardiovascular tops dulaglutide when treating patients with type 2 diabetes and CVD Semaglutide tops dulaglutide when treating
Description
In this piece, I share why most GLP-1 contracts reward the wrong outcome, the three commercial models that dominate this market, and where each one has an opportunity to improve, and how Twin built a commercial model that finally puts the vendor's incentives on the same side as yours.
GLP-1 patients: optimize your grocery shopping with this comprehensive guide
Learn more about who can get the drug, as well as the benefits and side effects.
Learn how Boulder Community Health offers compassionate, evidence-based obesity care
